slotkoers
Korea S.E.
00:00:00 21-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.047
KRW
|
-0,95%
|
|
0,00%
|
-37,75%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
211.555
|
169.679
|
140.585
|
88.518
|
82.676
|
59.868
|
Bedrijfswaarde
1 |
217.740
|
146.784
|
154.482
|
104.785
|
70.391
|
76.185
|
K/w-verhouding
|
52,6
x
|
-34
x
|
-25,3
x
|
-10,7
x
|
-11,5
x
|
-2,84
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
5,11
x
|
3,79
x
|
1,98
x
|
1,37
x
|
1,4
x
|
0,87
x
|
Bedrijfswaarde/omzet
|
5,26
x
|
3,28
x
|
2,18
x
|
1,62
x
|
1,19
x
|
1,11
x
|
Bedrijfswaarde/EBITDA
|
-319
x
|
-66,4
x
|
41,2
x
|
-15,1
x
|
-48,5
x
|
-19,8
x
|
Bedrijfswaarde/FCF
|
-14,9
x
|
-31,9
x
|
-4,98
x
|
-4,81
x
|
-24,6
x
|
-6,82
x
|
FCF Yield
|
-6,71%
|
-3,14%
|
-20,1%
|
-20,8%
|
-4,06%
|
-14,7%
|
Price to Book
|
7,32
x
|
2,77
x
|
2,45
x
|
1,22
x
|
0,9
x
|
0,75
x
|
Aantal aandelen (in duizenden)
|
12.300
|
17.053
|
17.442
|
20.049
|
30.849
|
35.593
|
Referentieprijs
2 |
17.200
|
9.950
|
8.060
|
4.415
|
2.680
|
1.682
|
Datum van publicatie
|
28/03/19
|
17/03/20
|
18/03/21
|
17/03/22
|
15/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
41.433
|
44.806
|
70.947
|
64.623
|
59.000
|
68.445
|
EBITDA
1 |
-683,3
|
-2.212
|
3.751
|
-6.925
|
-1.450
|
-3.854
|
Bedrijfsresultaat (EBIT)
1 |
-1.391
|
-3.332
|
2.225
|
-8.756
|
-3.411
|
-6.712
|
Operationele Marge
|
-3,36%
|
-7,44%
|
3,14%
|
-13,55%
|
-5,78%
|
-9,81%
|
Resultaat voor belastingen (EBT)
1 |
6.316
|
-6.208
|
-7.492
|
-3.299
|
-7.395
|
-21.059
|
Nettowinst (verlies)
1 |
3.720
|
-4.546
|
-5.488
|
-3.413
|
-6.779
|
-20.997
|
Nettomarge
|
8,98%
|
-10,15%
|
-7,73%
|
-5,28%
|
-11,49%
|
-30,68%
|
WPA
2 |
326,7
|
-293,0
|
-318,2
|
-413,0
|
-232,3
|
-593,0
|
Free Cash Flow
1 |
-14.617
|
-4.605
|
-31.033
|
-21.802
|
-2.860
|
-11.174
|
FCF-marge
|
-35,28%
|
-10,28%
|
-43,74%
|
-33,74%
|
-4,85%
|
-16,33%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/03/19
|
17/03/20
|
18/03/21
|
17/03/22
|
15/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
6.185
|
-
|
13.898
|
16.268
|
-
|
16.318
|
Nettokaspositie
1 |
-
|
22.895
|
-
|
-
|
12.285
|
-
|
Hefboom (schuld/ebitda)
|
-9,052
x
|
-
|
3,705
x
|
-2,349
x
|
-
|
-4,234
x
|
Free Cash Flow
1 |
-14.617
|
-4.605
|
-31.033
|
-21.802
|
-2.860
|
-11.174
|
ROE (netto-inkomsten/eigen vermogen)
|
16,8%
|
-10,1%
|
-9,26%
|
-4,94%
|
-7,88%
|
-24,2%
|
ROA (netto-inkomsten/totale activa)
|
-1,63%
|
-3,26%
|
1,38%
|
-4,34%
|
-1,58%
|
-2,75%
|
Totale activa
1 |
-228.739
|
139.304
|
-396.793
|
78.576
|
428.424
|
762.953
|
Nettoactief per aandeel
2 |
2.351
|
3.588
|
3.289
|
3.618
|
2.976
|
2.230
|
Cashflow per aandeel
2 |
684,0
|
1.404
|
1.303
|
1.144
|
1.284
|
729,0
|
Capex
1 |
527
|
1.323
|
45.582
|
2.306
|
2.851
|
16.823
|
Capex/omzet
|
1,27%
|
2,95%
|
64,25%
|
3,57%
|
4,83%
|
24,58%
|
Datum van publicatie
|
28/03/19
|
17/03/20
|
18/03/21
|
17/03/22
|
15/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -37,75% | 27,04 mln. | | +20,76% | 43,77 mld. | | +28,00% | 22,83 mld. | | +20,25% | 15,56 mld. | | +18,82% | 14,34 mld. | | +55,83% | 12,96 mld. | | -0,05% | 6,79 mld. | | -12,70% | 6,41 mld. | | -8,87% | 5,73 mld. | | +14,65% | 5,69 mld. |
Generieke geneesmiddelen
|